The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research Report 2024
Synopsis
MIGS has become a commonly used abbreviation in the glaucoma world. It stands for minimally invasive glaucoma surgery.
The global Minimally Invasive Glaucoma Surgery (MIGS) Devices market was valued at US$ 331.7 million in 2023 and is anticipated to reach US$ 1389.7 million by 2030, witnessing a CAGR of 22.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Minimally Invasive Glaucoma Surgery (MIGS) Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Minimally Invasive Glaucoma Surgery (MIGS) Devices.
Report Scope
The Minimally Invasive Glaucoma Surgery (MIGS) Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Minimally Invasive Glaucoma Surgery (MIGS) Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Minimally Invasive Glaucoma Surgery (MIGS) Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alcon
Ellex Medical Lasers
Glaukos
Allergan
Santen
Lumenis
Ivantis
Optonol
iSTAR Medical
InnFocus
Bausch＆Lomb
Neomedix
IOPtima
Johnson & Johnson
Carl-Zeiss
New World Medical
Segment by Type
Check Equipment
Treatment Equipment
Other
Segment by Application
Hospital
Ambulatory surgical centers
Ophthalmology clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Minimally Invasive Glaucoma Surgery (MIGS) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Minimally Invasive Glaucoma Surgery (MIGS) Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
MIGS has become a commonly used abbreviation in the glaucoma world. It stands for minimally invasive glaucoma surgery.
The global Minimally Invasive Glaucoma Surgery (MIGS) Devices market was valued at US$ 331.7 million in 2023 and is anticipated to reach US$ 1389.7 million by 2030, witnessing a CAGR of 22.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Minimally Invasive Glaucoma Surgery (MIGS) Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Minimally Invasive Glaucoma Surgery (MIGS) Devices.
Report Scope
The Minimally Invasive Glaucoma Surgery (MIGS) Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Minimally Invasive Glaucoma Surgery (MIGS) Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Minimally Invasive Glaucoma Surgery (MIGS) Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alcon
Ellex Medical Lasers
Glaukos
Allergan
Santen
Lumenis
Ivantis
Optonol
iSTAR Medical
InnFocus
Bausch＆Lomb
Neomedix
IOPtima
Johnson & Johnson
Carl-Zeiss
New World Medical
Segment by Type
Check Equipment
Treatment Equipment
Other
Segment by Application
Hospital
Ambulatory surgical centers
Ophthalmology clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Minimally Invasive Glaucoma Surgery (MIGS) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Minimally Invasive Glaucoma Surgery (MIGS) Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
1.1 Product Overview and Scope of Minimally Invasive Glaucoma Surgery (MIGS) Devices
1.2 Minimally Invasive Glaucoma Surgery (MIGS) Devices Segment by Type
1.2.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Value Comparison by Type (2024-2030)
1.2.2 Check Equipment
1.2.3 Treatment Equipment
1.2.4 Other
1.3 Minimally Invasive Glaucoma Surgery (MIGS) Devices Segment by Application
1.3.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Ambulatory surgical centers
1.3.4 Ophthalmology clinics
1.4 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Estimates and Forecasts
1.4.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue 2019-2030
1.4.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales 2019-2030
1.4.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competition by Manufacturers
2.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Average Price by Manufacturers (2019-2024)
2.4 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Minimally Invasive Glaucoma Surgery (MIGS) Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Minimally Invasive Glaucoma Surgery (MIGS) Devices, Product Type & Application
2.7 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Situation and Trends
2.7.1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Minimally Invasive Glaucoma Surgery (MIGS) Devices Players Market Share by Revenue
2.7.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Minimally Invasive Glaucoma Surgery (MIGS) Devices Retrospective Market Scenario by Region
3.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Region: 2019-2030
3.2.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Region: 2019-2024
3.2.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Region: 2025-2030
3.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region: 2019-2030
3.3.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region: 2019-2024
3.3.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region: 2025-2030
3.4 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Country
3.4.1 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Country (2019-2030)
3.4.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Country
3.5.1 Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Country (2019-2030)
3.5.3 Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Country
3.7.1 Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Country (2019-2030)
3.7.3 Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Type (2019-2030)
4.1.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Type (2019-2024)
4.1.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Type (2025-2030)
4.1.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share by Type (2019-2030)
4.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Type (2019-2030)
4.2.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Type (2019-2024)
4.2.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Type (2025-2030)
4.2.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Type (2019-2030)
4.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Application (2019-2030)
5.1.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Application (2019-2024)
5.1.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales by Application (2025-2030)
5.1.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share by Application (2019-2030)
5.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Application (2019-2030)
5.2.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Application (2019-2024)
5.2.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue by Application (2025-2030)
5.2.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Application (2019-2030)
5.3 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Alcon
6.1.1 Alcon Corporation Information
6.1.2 Alcon Description and Business Overview
6.1.3 Alcon Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Alcon Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.1.5 Alcon Recent Developments/Updates
6.2 Ellex Medical Lasers
6.2.1 Ellex Medical Lasers Corporation Information
6.2.2 Ellex Medical Lasers Description and Business Overview
6.2.3 Ellex Medical Lasers Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ellex Medical Lasers Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.2.5 Ellex Medical Lasers Recent Developments/Updates
6.3 Glaukos
6.3.1 Glaukos Corporation Information
6.3.2 Glaukos Description and Business Overview
6.3.3 Glaukos Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glaukos Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.3.5 Glaukos Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Santen
6.5.1 Santen Corporation Information
6.5.2 Santen Description and Business Overview
6.5.3 Santen Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Santen Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.5.5 Santen Recent Developments/Updates
6.6 Lumenis
6.6.1 Lumenis Corporation Information
6.6.2 Lumenis Description and Business Overview
6.6.3 Lumenis Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lumenis Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.6.5 Lumenis Recent Developments/Updates
6.7 Ivantis
6.6.1 Ivantis Corporation Information
6.6.2 Ivantis Description and Business Overview
6.6.3 Ivantis Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ivantis Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.7.5 Ivantis Recent Developments/Updates
6.8 Optonol
6.8.1 Optonol Corporation Information
6.8.2 Optonol Description and Business Overview
6.8.3 Optonol Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Optonol Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.8.5 Optonol Recent Developments/Updates
6.9 iSTAR Medical
6.9.1 iSTAR Medical Corporation Information
6.9.2 iSTAR Medical Description and Business Overview
6.9.3 iSTAR Medical Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 iSTAR Medical Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.9.5 iSTAR Medical Recent Developments/Updates
6.10 InnFocus
6.10.1 InnFocus Corporation Information
6.10.2 InnFocus Description and Business Overview
6.10.3 InnFocus Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 InnFocus Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.10.5 InnFocus Recent Developments/Updates
6.11 Bausch＆Lomb
6.11.1 Bausch＆Lomb Corporation Information
6.11.2 Bausch＆Lomb Minimally Invasive Glaucoma Surgery (MIGS) Devices Description and Business Overview
6.11.3 Bausch＆Lomb Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bausch＆Lomb Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.11.5 Bausch＆Lomb Recent Developments/Updates
6.12 Neomedix
6.12.1 Neomedix Corporation Information
6.12.2 Neomedix Minimally Invasive Glaucoma Surgery (MIGS) Devices Description and Business Overview
6.12.3 Neomedix Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Neomedix Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.12.5 Neomedix Recent Developments/Updates
6.13 IOPtima
6.13.1 IOPtima Corporation Information
6.13.2 IOPtima Minimally Invasive Glaucoma Surgery (MIGS) Devices Description and Business Overview
6.13.3 IOPtima Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 IOPtima Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.13.5 IOPtima Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Corporation Information
6.14.2 Johnson & Johnson Minimally Invasive Glaucoma Surgery (MIGS) Devices Description and Business Overview
6.14.3 Johnson & Johnson Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Johnson & Johnson Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
6.15 Carl-Zeiss
6.15.1 Carl-Zeiss Corporation Information
6.15.2 Carl-Zeiss Minimally Invasive Glaucoma Surgery (MIGS) Devices Description and Business Overview
6.15.3 Carl-Zeiss Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Carl-Zeiss Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.15.5 Carl-Zeiss Recent Developments/Updates
6.16 New World Medical
6.16.1 New World Medical Corporation Information
6.16.2 New World Medical Minimally Invasive Glaucoma Surgery (MIGS) Devices Description and Business Overview
6.16.3 New World Medical Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 New World Medical Minimally Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.16.5 New World Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry Chain Analysis
7.2 Minimally Invasive Glaucoma Surgery (MIGS) Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Minimally Invasive Glaucoma Surgery (MIGS) Devices Production Mode & Process
7.4 Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales and Marketing
7.4.1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Channels
7.4.2 Minimally Invasive Glaucoma Surgery (MIGS) Devices Distributors
7.5 Minimally Invasive Glaucoma Surgery (MIGS) Devices Customers
8 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
8.1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry Trends
8.2 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Drivers
8.3 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Challenges
8.4 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
